Norovirus bivalent vaccine (Takeda)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameNorovirus bivalent vaccine (Takeda)
Drug Alias NameNorovirus intramuscular vaccineNorovirus GI.1/GII.4 bivalent VLP vaccineNorovirus bivalent VLP vaccineNorovirus IM vaccineTAK-214 +[6] 
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsNorovirus InfectionsGastroenteritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumPanamaUnited States +[10] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesLigocyte
China Registration ClassN/A

Develop Information

Active CompaniesTakeda Pharmaceutical Co LtdHilleVax Inc
Inactive CompaniesN/A
Active IndicationsNorovirus InfectionsGastroenteritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A